Chongqing Pharscin Pharmaceutical Co.,Ltd.’s Net Profit Rose 2.6% in First Quarter of 2023

Chongqing Pharscin Pharmaceutical Co.,Ltd. (重庆华森制药股份有限公司) (002907.SZ) reported a net profit of 30.1 million yuan in the first quarter of 2023, up 2.6% year-on-year.

Meanwhile, the company posted 187.5 million yuan in revenue, down 7.6% year-on-year.

At the end of the reporting period, it had 1.9 billion yuan in total assets and 300 million yuan in total liabilities, with a liability-to-asset ratio of 15.5%.